Arcadia Biosciences
RKDA
19 hedge funds and large institutions have $2.82M invested in Arcadia Biosciences in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
99% more capital inflows, than outflows
Capital inflows: $1.52M | Capital outflows: $767K
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
6% more funds holding
Funds holding: 18 → 19 (+1)
2.31% more ownership
Funds ownership: 8.12% → 10.43% (+2.3%)
37% less call options, than puts
Call options by funds: $88K | Put options by funds: $139K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$840K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$504K |
| 3 |
GSA Capital Partners
London,
United Kingdom
|
+$82.8K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$35.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$741K |
| 2 |
Tower Research Capital (TRC)
New York
|
-$7.94K |
| 3 |
BNC Wealth Management
Beaverton,
Oregon
|
-$7K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$4.64K |
| 5 |
Morgan Stanley
New York
|
-$3.05K |
RKDA Hedge Fund Activity: Q4 2020 in Review
19 of the 5,680 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2020, worth a combined $2.82M — up 16% from $2.44M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RKDA positions and 1 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Ardsley Advisory Partners, adding an estimated $840K. The largest seller was Sabby Management, cutting an estimated $741K.
- 19 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2020, up from 18 in Q3 2020.
- Funds reported $2.82M of Arcadia Biosciences stock for Q4 2020, up 16% quarter-over-quarter.
- 2 funds opened new Arcadia Biosciences positions in Q4 2020 and 1 closed out, a net change of +1 holder.
- The largest Arcadia Biosciences buyer in Q4 2020 was Ardsley Advisory Partners, an estimated $840K added.
- The largest Arcadia Biosciences seller in Q4 2020 was Sabby Management, an estimated $741K sold.
Based on aggregated 13F filings for Q4 2020.